Equity Events is a Brisbane based company which specialises in organising investment events for the mining, energy, exploration and industrial sectors. Each year the host the very successful Noosa Mining Conference.
Copyright 2024 – Finance News Network
07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
12 Apr 2024 - A pre-IPO interview with Cameron Woodrow, the Executive Director and CEO of Far Northern Resources Limited (ASX:FNR). Mr Woodrow discusses development of the company's three gold and base metals projects in the Northern Territory and north Queensland.
07 Mar 2023 - Eureka Group Holdings Limited (ASX:EGH) CEO Cameron Taylor provides an overview of the company, discussing positioning in the industry, strategy, the new development in Brassall, Queensland, government assistance and growth opportunities.
03 Dec 2019 - Noxopharm Limited (ASX:NOX) Executive Chairman & CEO, Dr Graham Kelly, discusses clinical results from the company's Phase 1b clinical DARRT-1 trial for its lead product candidate, Veyonda, with low-dose radiotherapy.
03 February 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar talks about the company's collaboration agreement with the Walter Reed Army Institute of Research and UNSW into the study of a first-ever pharmaceutical treatment for traumatic brain injury, a top health priority for the military.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
26 Aug 2024 - BluGlass Limited (ASX:BLG) CEO Jim Haden discusses the company's record quarter, IP deals, customer engagement and the upcoming Semiconductor Australia conference.
16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.
16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.